EUVIMEDEUVIMED entdecken
Crossref

Trends in Deep Vein Thrombosis Prophylaxis After Total Knee Arthroplasty: 2016 to 2021

Jeremy A Dubin, Sandeep S Bains, Daniel Hameed, Ethan A Remily, Mallory C Moore, Michael A Mont, James Nace, Ronald E Delanois

The Journal of Arthroplasty · 2024-08 · 39 (8) · S328-S332

DOI: 10.1016/j.arth.2024.01.050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2024-08. Verfasst von Jeremy A Dubin und 7 weiteren Autor:innen. Beteiligte Einrichtung: LifeBridge Health, Sinai Hospital of Baltimore, Rubin Institute for Advanced Orthopedics, Baltimore, Maryland. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Venous Thrombosis, Anticoagulants, Aspirin. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In 2011, the American Academy of Orthopaedic Surgeons released a consensus recommending venous thromboembolism (VTE) prophylaxis after total knee arthroplasty (TKA). The purpose of our study was to examine (1) incidences of postoperative complications, including pulmonary embolism (PE), deep vein thrombosis (DVT), and transfusion rates; (2) trends from 2016 to 2021 in VTE prophylaxis; and (3) independent risk factors for 90-day total complications following TKA between aspirin, enoxaparin, rivaroxaban, and warfarin. METHODS: Using a national, all-payer database from 2016 to 2021, we identified all patients who underwent primary TKA. Exclusions included all patients who had prescribed anticoagulants within 1 year prior to TKA, hypercoagulable states, and cancer. Data were collected on baseline demographics, including age, sex, diabetes, and a comorbidity index, in each of the VTE prophylaxis cohorts. Postoperative outcomes included rates of PE, DVT, and transfusion. Multivariable regressions were performed to determine independent risk factors for total complications at 90 days following TKA. RESULTS: From 2016 to 2021, aspirin was the most used anticoagulant (n = 62,054), followed by rivaroxaban (n = 26,426), enoxaparin (n = 20,980), and warfarin (n = 13,305). The cohort using warfarin had the highest incidences of PE (1.8%) and DVT (5.7%), while the cohort using aspirin had the lowest incidences of PE (0.6%) and DVT (1.6%). The rates of aspirin use increased the most from 2016 to 2021 (32.1% to 70.8%), while the rates of warfarin decreased the most (19.3% to 3.0%). Enoxaparin, rivaroxaban, and warfarin were independent risk factors for total complications at 90 days. CONCLUSIONS: An epidemiological analysis of VTE prophylaxis use from 2016 to 2021 shows an increase in aspirin following TKA compared to other anticoagulant cohorts in a nationally representative population. This approach provides more insight and a better understanding of anticoagulation trends over this time period in a nationally representative sample.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthroplasty, Replacement, KneeVenous ThrombosisAnticoagulantsAspirinWarfarinEnoxaparinPostoperative ComplicationsPulmonary EmbolismHumansFemaleMaleAgedMiddle AgedRisk FactorsIncidenceRivaroxabanBlood TransfusionVenous ThromboembolismRetrospective StudiesAged, 80 and over

Stichwörter der Autor:innen

arthroplastyaspirinkneeprophylaxisvenous thromboembolism

Substanzen

AnticoagulantsAspirinWarfarinEnoxaparinRivaroxaban

Autor:innen und Institutionen

  • LifeBridge Health, Sinai Hospital of Baltimore, Rubin Institute for Advanced Orthopedics, Baltimore, Maryland.

Zitieren

APA

Dubin, J. A., Bains, S. S., Hameed, D., Remily, E. A., Moore, M. C., Mont, M. A., Nace, J., & Delanois, R. E. (2024). Trends in Deep Vein Thrombosis Prophylaxis After Total Knee Arthroplasty: 2016 to 2021. The Journal of Arthroplasty, 39(8), S328-S332. https://doi.org/10.1016/j.arth.2024.01.050

Vancouver

Dubin JA, Bains SS, Hameed D, Remily EA, Moore MC, Mont MA, et al. Trends in Deep Vein Thrombosis Prophylaxis After Total Knee Arthroplasty: 2016 to 2021. The Journal of Arthroplasty. 2024;39(8):S328-S332. doi:10.1016/j.arth.2024.01.050

BibTeX
@article{Dubin2024,
  author = {Dubin, Jeremy A and Bains, Sandeep S and Hameed, Daniel and Remily, Ethan A and Moore, Mallory C and Mont, Michael A and Nace, James and Delanois, Ronald E},
  title = {Trends in Deep Vein Thrombosis Prophylaxis After Total Knee Arthroplasty: 2016 to 2021},
  journal = {The Journal of Arthroplasty},
  year = {2024},
  volume = {39},
  number = {8},
  pages = {S328--S332},
  doi = {10.1016/j.arth.2024.01.050}
}
Kostenlos starten →